ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,076Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 113

$556K Total Retail Price of All Prescriptions

Rank: 23 out of 113

714 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 714 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 714 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 10,466 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
SIMVASTATIN 693 617 1 2
LEVOTHYROXINE SODIUM 559 528 2 1
WARFARIN SODIUM 389 357 3 8
LISINOPRIL 343 303 4 3
ATENOLOL 317 296 5 16
AMLODIPINE BESYLATE 304 291 6 4
FUROSEMIDE 275 239 7 6
OMEPRAZOLE 267 212 8 5
HYDROCODONE-ACETAMINOPHEN 266 175 S3 9 7
POTASSIUM CHLORIDE 256 232 10 12
HYDROCHLOROTHIAZIDE 256 244 10 9
SERTRALINE HCL 237 225 12 21
METOPROLOL SUCCINATE 199 189 13 10
METOPROLOL TARTRATE 180 156 14 14
DONEPEZIL HCL 180 180 14 33
ZOLPIDEM TARTRATE 176 130 16 19
ALENDRONATE SODIUM 170 169 17 22
ATORVASTATIN CALCIUM 157 145 18 15
LOSARTAN POTASSIUM 148 147 19 13
BENAZEPRIL HCL 123 113 20 46
MELOXICAM 116 96 21 44
FLUOXETINE HCL 115 86 22 31
CITALOPRAM HBR 114 97 23 17
METFORMIN HCL 113 92 24 11
TRAMADOL HCL 108 92 25 29
TRIAMTERENE-HCTZ 106 104 26 26
DIGOXIN 101 101 27 27
KLOR-CON M20 97 89 28 60
LISINOPRIL-HYDROCHLOROTHIAZIDE 94 94 29 34
PANTOPRAZOLE SODIUM 91 74 30 52
GLYBURIDE 90 90 R 31 66
PRAVASTATIN SODIUM 89 89 32 23
GABAPENTIN 89 76 32 18
CARVEDILOL 89 83 32 25
METFORMIN HCL ER 86 64 35 51
SPIRONOLACTONE 84 74 36 32
GLIMEPIRIDE 84 75 36 36
DIOVAN 75 75 38 42
CYMBALTA 70 45 39 37
LANTUS SOLOSTAR 69 62 40 59
PEN NEEDLE 68 43 41 94
PAROXETINE HCL 65 53 42 45
ADVAIR DISKUS 65 56 42 35
TRIAMTERENE-HYDROCHLOROTHIAZID 61 56 44 91
SYNTHROID 60 55 45 57
NAMENDA 60 60 45 48
GEMFIBROZIL 59 42 47 61
VENLAFAXINE HCL ER 59 36 47 55
LOVASTATIN 58 57 49 53
TRAZODONE HCL 56 37 50 41
GLIPIZIDE 56 51 50 75
AMITRIPTYLINE HCL 55 52 R 52 58
LANTUS 55 27 52 38
QUETIAPINE FUMARATE 55 55 52 83
ESTRADIOL 54 42 R 55 157
NEXIUM 54 41 55 47
PREDNISONE 54 53 55 28
SPIRIVA 52 36 58 54
CYCLOBENZAPRINE HCL 51 22 R 59 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.